SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial
media network dedicated to the North American cannabis industry, announces publication of an article covering Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS). Pure Global is a
growth-oriented life sciences cannabis company which plans to serve the market based on its research driven medical cannabis
strategy. Pure recently announced that it is launching eight product lines for medical cannabis patients under the company’s
PureSinse packaging label.
Innovative Medical Cannabis and Health & Wellness Products
The new PureSinse product line includes eight stock keeping units (SKUs) featuring a wide spectrum of products, formulations and
infusions for the medical and health & wellness markets. The elegant, eco-friendly, and sustainable packaging speaks to the
PureSinse culture of providing its clientele with exceptional product offerings and customer experience across all aspects of the
company’s offerings. An assortment of dried flower, cannabis oils, softgels, topicals, sublinguals, transdermals, edibles, and vape
products are in the advance stages of development to make them readily available to meet patients' individual needs once the
company has received Health Canada sales license, which could happen in the next few weeks.
In further developments, the Company is expecting to unveil a user-friendly eCommerce website that will enable medical cannabis
patients to register with PureSinse, order medical cannabis online, and enjoy discreet delivery via registered courier in selected
areas.
Health Canada Sales License
PureSinse recently completed the physical on-site inspections required by Health Canada prior to being granted a sales license
to supply cannabis products to medical patients, as well legal adult markets, under the newly implemented Cannabis Act 2018. “We
are confident that the Company meets all the safety, quality assurance, security, and record keeping requirements,” said Malay
Panchal, CEO of Pure Global. “The inspection by Health Canada was one of the last steps prior to issuing a sales license, which
will be a significant milestone for the company enabling sale of cannabis inventories to registered medical patients and provincial
distributors, and the initiation of revenues for the company.”
About PureSinse
PureSinse, a wholly owned subsidiary of Pure Global, Inc, has demonstrated a commitment to a clinical approach that stems from
the company’s pharmacy and physician roots. “The PureSinse brand is focused on patients,” according to Cheryl Pim, Director of New
Product Development. “We will be tracking clinical outcomes through real-world studies to ensure our product lines are consistent,
tailored, and available. Patients rely on consistency and dependability for their medical needs, and our research and data-driven
approach will ensure our products and methods improve and evolve with the needs of our patients over time.”
Pure Global’s Brampton Operation
Pure’s commitment to continuous improvement and innovation is further evident in Pure Global’s recent acquisition of CO2
extraction, high-capacity robotic capsules, oil bottles, and vape pen cartridge filling equipment. The company’s Brampton campus
has quickly transformed into a hub for a vertically farmed cultivation, high capacity extraction, laboratory testing, research and
development, and a manufacturing center for branded and private label products for the wellness, food & beverage, natural health,
and pharmaceutical markets.
In Brampton Phase 2 & Phase 3 construction of Pure’s 41,000 square foot production facility will include automated controlled
growth cultivation systems that feature the company’s vertical farming methods. This proprietary vertical farming
system enables the facility to grow multiple tiers of canopy, exponentially increasing potential yield from the same square
footage, without the use of pesticides or herbicides. Upon expected completion in Q3 or Q4 of 2019, Pure’s Brampton
production facility is anticipated to have a production capacity of minimum 8,000 kilograms.
Patient Focused Solutions for Improved Patient Outcomes
To support Pure’s continued focus on innovations in medical cannabis with the aim of helping patients across the globe, the
company recently welcomed Dr. Sanjeev Goel to the PureSinse team as Chief Medical Officer. Dr. Goel, with a wealth of experience in
the industry, has been a pioneer in medical cannabis. He led the formation of two resource centers for medical cannabis with over
3,000 patients registered with licensed producers in Canada. Dr. Goel is founder and CEO for an integrative medical practice using
cutting-edge medical treatments for patients across Canada, the founder of a not-for-profit organization dedicated to empowering
health care providers to improve patient care, as well as a healthcare software company to improve patient quality of care by
developing the largest primary care patient portal in Canada.
Dr. Goel will provide direction on projects supporting medical cannabis patients, primarily having to do with patient care
experience and physician education. He will also act as the lead liaison with doctors and medical professionals, to provide
guidance on medical cannabis and systems to ensure efficient, accurate patient care.
“I am thrilled to add Dr. Goel to our core team to help deliver patient-focused solutions enabling better education and
ultimately improved patient outcomes”, said Malay Panchal. “Dr. Goel’s extensive experience as a practicing physician will allow
him to offer advice regarding clinical research projects, strategies to address the needs of wellness customers, and ways to
integrate existing and new wellness products.”
With these recent positive developments, Pure Global Inc appears to be a company to watch as a potential leader in the cannabis
industry in Canada and worldwide.
For further information, please visit their website: pureglobal.com
Please follow the link to read the full article: http://www.cannabisfn.com/pure-global-poised-advance-innovative-products-distribution-channels/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps
companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in
the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own
independent legal, tax, and/or investment professionals before making any investment decisions. The information provided
on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid
advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm
enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other
editorials for advertising such companies. We are not an independent news media provider. We make no warranty or
representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly
and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As
such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted.
CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along
with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create
awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Contact
CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com
